Origin and maintenance of the intestinal cancer stem cell

Molecular Carcinogenesis

Volumn 50, Issue 4, 2011, Pages 254-263

  Davies, Emma J ^a   Marsh, Victoria ^a   Clarke, Alan R ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Cancer stem cells; Intestine; Wnt pathway

Indexed keywords

BONE MORPHOGENETIC PROTEIN; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; WNT PROTEIN;

ARTICLE; BONE MARROW CELL; CANCER STEM CELL; CELL INTERACTION; CELL LINEAGE; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CLINICAL RESEARCH; HUMAN; INTESTINE CANCER; INTESTINE EPITHELIUM CELL; MUTATION; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; STROMA;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; COLORECTAL NEOPLASMS; HUMANS; INTESTINES; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 79953331014     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20631     Document Type: Article

References (88)

1. CancerResearchUK. Cancer worldwide-common cancers. 2005.
2. Ahmed FE. Effect of diet, life style, and other environmental/chemopreventive factors on colorectal cancer development, and assessment of the risks. J Environ Sci Health C 2004; 22: 91-147.
3. Leedham SJ, Brittan M, McDonald SAC, Wright NA. Intestinal stem cells. J Cell Mol Med 2005; 9: 11-24.
4. Potten CS, Booth C, Mark Pritchard D. The intestinal epithelial stem cell: The mucosal governor. Int J Exp Pathol 1997; 78: 219-243.
5. Ponder BAJ, Schmidt GH, Wilkinson MM. Derivation of mouse intestinal crypts from single progenitor cells. Nature 1985; 313: 689-691.
6. Winton DJ, Ponder BAJ. Stem-cell organization in mouse small intestine. Proc R Soc Biol Sci Ser B 1990; 241: 13-18.
7. Potten CS, Owen G, Roberts SA. The temporal and spatial changes in cell proliferation within the irradiated crypts of the murine small intestine. Int J Radiat Biol 1990; 57: 185-199.
8. Potten CS, Kellett M, Roberts SA, Rew DA, Wilson GD. Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut 1992; 33: 71-78.
9. Deheragoda M, Wright N. An update on the pathophysiology of the intestinal crypt. Curr Diagn Pathol 2006; 12: 268-278.
10. Sancho E, Batlle E, Clevers H. Live and let die in the intestinal epithelium. Curr Opin Cell Biol 2003; 15: 763-770.
11. Brittan M, Wright NA. Stem cell in gastrointestinal structure and neoplastic development. Gut 2004; 53: 899-910.
12. Wicha MS, Liu S, Dontu G. Cancer stem cells: An old idea-A paradigm shift. Cancer Res 2006; 66: 1883-1890.
13. Trosko JE, Tai MH. Adult stem cell theory of the multi-stage, multi-mechanism theory of carcinogenesis: Role of inflammation on the promotion of initiated stem cells. Contrib Microbiol 2006; 13: 45-65.
14. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111.
15. Hamburger A, Salmon SS. Primary bioassay of human myeloma stem cells. J Clin Invest 1977; 60: 846-854.
16. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-737.
17. Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104: 10158-10163.
18. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110.
19. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115.
20. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988.
21. Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007; 67: 1030-1037.
22. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-5828.
23. Cocciadiferro L, Miceli V, Kang KS, Polito LM, Trosko JE, Carruba G. Profiling cancer stem cells in androgen-responsive and refractory human prostate tumor cell lines. Ann N Y Acad Sci 2009; 1155: 257-262.
24. Hill RP. Identifying cancer stem cells in solid tumors: Case not proven. Cancer Res 2006; 66: 1891-1896.
25. Lee CH, Xue H, Sutcliffe M, et al. Establishment of subrenal capsule xenografts of primary human ovarian tumors in SCID mice: Potential models. Gynecol Oncol 2005; 96: 48-55.
26. Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007; 104: 973-978.
27. Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr Opin Biotechnol 2007; 18: 460-466.
28. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 2007; 317: 337.
29. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
30. Trosko JE. Review paper: Cancer stem cells and cancer nonstem cells: From adult stem cells or from reprogramming of differentiated somatic cells. Vet Pathol 2009; 46: 176-193.
31. Sell S. Cellular origin of cancer: Dedifferentiation or stem cell maturation arrest? Environ Health Perspect 1993; 101: 15-26.
32. Trosko JE. Commentary: "Re-programming or selecting adult stem cells?" Stem Cell Rev 2008; 4: 81-88.
33. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105: 369-377.
34. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
35. Potten CS, Owen G, Booth D. Intestinal stem cells protect their genome by selective segregation of template DNA strands. J Cell Sci 2002; 115: 2381-2388.
36. Fevr T, Robine S, Louvard D, Huelsken J. Wnt/β-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol Cell Biol 2007; 27: 7551-7559.
37. Booth C, Potten CS. Gut instincts: Thoughts on intestinal epithelial stem cells. J Clin Invest 2000; 105: 1493-1499.
38. Potten CS. Stem cells in gastrointestinal epithelium: Numbers, characteristics and death. Philos Trans R Soc Lond B Biol Sci 1998; 353: 821-830.
39. Potten CS, Booth C, Hargreaves D. The small intestine as a model for evaluating adult tissue stem cell drug targets. Cell Prolif 2003; 36: 115-129.
40. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 2001; 107: 1395-1402.
41. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6: 1229-1234.
42. Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279: 1528-1530.
43. Eglitis MA, Mezey E. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc Natl Acad Sci USA 1997; 94: 4080-4085.
44. Hayashi Y, Tsuji S, Tsujii M, et al. The transdifferentiation of bone-marrow-derived cells in colonic mucosal regeneration after dextran-sulfate-sodium-induced colitis in mice. Pharmacology 2007; 80: 193-199.
45. Bruscia EM, Ziegler EC, Price JE, Weiner S, Egan ME, Krause DS. Engraftment of donor-derived epithelial cells in multiple organs following bone marrow transplantation into newborn mice. Stem Cells 2006; 24: 2299-2308.
46. Okamoto R, Yajima T, Yamazaki M, et al. Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med 2002; 8: 1011-1017.
47. Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306: 1568-1571.
48. Curtis RE, Rowlings PA, Deeg HJ, et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997; 336: 897-904.
49. Cogle CR, Theise ND, Fu D, et al. Bone marrow contributes to epithelial cancers in mice and humans as developmental mimicry. Stem Cells 2007; 25: 1881-1887.
50. Rizvi AZ, Swain JR, Davies PS, et al. Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci USA 2006; 103: 6321-6325.
51. Potten CS, Booth C, Tudor GL, et al. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 2003; 71: 28-41.
52. Barker N, Van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003-1007.
53. May R, Riehl T, Hunt C, Sureban SM, Anant S, Houchen CW. Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker: DCAMKL-1 following radiation injury and in APC/Min mice. Stem Cells 2008; 26: 630-637.
54. Giannakis M, Stappenbeck TS, Mills JC, et al. Molecular properties of adult mouse gastric and intestinal epithelial progenitors in their niches. J Biol Chem 2006; 281: 11292-11300.
55. Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet 2008; 40: 915-920.
56. Bjerknes M, Cheng H. Gastrointestinal stem cells. II. Intestinal stem cells. Am J Physiol 2005; 289: G381-G387.
57. Barker N, Ridgway RA, van Es JH, et al. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009. 457: 608-611.
58. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
59. Vermeulen L, Todaro M, De Sousa Mello F, et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA 2008; 105: 13427-13432.
60. Nishide K, Nakatani Y, Kiyonari H, Kondo T. Glioblastoma formation from cell population depleted of Prominin1-expressing cells. PLoS One 2009; 4: e6869.
61. Zhu L, Gibson P, Currle DS, et al. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009; 457: 603-607.
62. Shmelkov SV, Butler JM, Hooper AT, et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 2008; 118: 2111-2120.
63. Alison MR. Tissue-based stem cells: ABC transporter proteins take centre stage. J Pathol 2003; 200: 547-550.
64. Hirschmann-Jax C, Foster AE, Wulf GG, et al. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 2004; 101: 14228-14233.
65. Dekaney CM, Rodriguez JM, Graul MC, Henning SJ. Isolation and characterization of a putative intestinal stem cell fraction from mouse jejunum. Gastroenterology 2005; 129: 1567-1580.
66. Alison MR, Poulsom R, Brittan M, Schier S, Burkert J, Wright NA. Isolation of gut SP cells does not automatically enrich for stem cells. Gastroenterology 2006; 130: 1012-1013.
67. Burkert J, Otto WR, Wright NA. Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol 2008; 214: 564-573.
68. Bach SP, Renehan AG, Potten CS. Stem cells: The intestinal stem cell as a paradigm. Carcinogenesis 2000; 21: 469-476.
69. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005; 434: 843-850.
70. Ireland H, Kemp R, Houghton C, et al. Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: Effect of loss of β-catenin. Gastroenterology 2004; 126: 1236-1246.
71. Sansom OJ, Reed KR, Hayes AJ, et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 2004; 18: 1385-1390.
72. Andreu P, Colnot S, Godard C, et al. Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Development 2005; 132: 1443-1451.
73. Wilson A, Radtke F. Multiple functions of Notch signaling in self-renewing organs and cancer. FEBS Lett 2006; 580: 2860-2868.
74. van Es JH, van Gijn ME, Riccio O, et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 2005; 435: 959-963.
75. Fre S, Huyghe M, Mourikis P, Robine S, Louvard D, Artavanis-Tsakonas S. Notch signals control the fate of immature progenitor cells in the intestine. Nature 2005; 435: 964-968.
76. Ishizuya-Oka A. Epithelial-connective tissue cross-talk is essential for regeneration of intestinal epithelium. J Nippon Med Sch 2005; 72: 13-18.
77. Chow E, Macrae F. A review of juvenile polyposis syndrome. J Gastroenterol Hepatol 2005; 20: 1634-1640.
78. He XC, Zhang J, Tong WG, et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nat Genet 2004; 36: 1117-1121.
79. Haramis APG, Begthel H, Van Den Born M, et al. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 2004; 303: 1684-1686.
80. Sheng H, Shao J, Townsend CM, Jr., Evers BM. Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells. Gut 2003; 52: 1472-1478.
81. He XC, Yin T, Grindley JC, et al. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet 2007; 39: 189-198.
82. Kuperwasser C, Chavarria T, Wu M, et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 2004; 101: 4966-4971.
83. Bhowmick NA, Chytil A, Plieth D, et al. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303: 848-851.
84. Beppu H, Mwizerwa ON, Beppu Y, et al. Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation. Oncogene 2008; 27: 1063-1070.
85. Kaestner KH, Silberg DG, Traber PG, Schütz G. The mesenchymal winged helix transcription factor Fkh6 is required for the control of gastrointestinal proliferation and differentiation. Genes Dev 1997; 11: 1583-1595.
86. Perreault N, Katz JP, Sackett SD, Kaestner KH. Foxl1 controls the Wnt/β-catenin pathway by modulating the expression of proteoglycans in the gut. J Biol Chem 2001; 276: 43328-43333.
87. Marsh V, Winton DJ, Williams GT, et al. Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation. Nat Genet 2008; 40: 1436-1444.
88. Todaro M, Alea MP, Di Stefano AB, et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007; 1: 389-402.